Newark, CA, United States of America

Oraya Therapeutics, Inc.


USPTO Granted Patents = 50

% Expired Patents = 58.0



Forward Citations = 1,467

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Michael Eric Gertner (50 out of 106 patents)

silverMedal Steven D Hansen (28 out of 29 patents)

bronzeMedal Erik Chell (22 out of 26 patents)

4.  Mark E Arnoldussen (17 out of 31 patents)

5.  Matt Herron (17 out of 23 patents)

6.  Junzhong Liang (9 out of 35 patents)

7.  Igor Koruga (3 out of 3 patents)

8.  Kuang-Hung Pan (3 out of 3 patents)


Core Competencies:
Orthovoltage Radiotherapy
Ocular Radiosurgery
Radiation Delivery
Treatment Planning
Portable Radiotherapy
Eye Positioning
Ocular Alignment
Radiosurgery Devices
Radiation Control
Predicting Delivery
Stabilizing Eye
Ocular Structures

50 patents:

Company Overview
Oraya Therapeutics, Inc. is a medical technology company based in Newark, California, specializing in orthovoltage radiotherapy. The organization focuses on developing innovative solutions for ocular radiosurgery, aiming to enhance radiation delivery and treatment planning for eye conditions. Their expertise includes portable radiotherapy systems and advanced eye positioning techniques, which are designed to improve the precision and effectiveness of radiosurgery devices. Oraya Therapeutics is dedicated to advancing patient care through cutting-edge technology in the field of ocular health.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

50 Patents

#9 in Newark, CA

#1,650 in California

#7,009 in US

#14,013 in the World

Newark, CA (US)
Newark, CA, United States of America
Forward Citations = 1,467

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oraya Therapeutics, Inc.. Retrieved from https://idiyas.com/company/oraya-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…